tbtadmin
02-26-2009, 10:12 PM
Last week, Dr. Gail Naughton, CEO of Histrogen, Inc. a regenerative medicine company that develops solutions based on the products of *newborn fibroblasts grown under embryonic conditions, addressed attendees at the 4th Annual Stem Cell Summit in New York. Dr. Naughton presented preliminary mid-trial results from Histrogen’s first human clinical evaluation of *it’s promising breakthrough [...]
More... (http://www.thebaldtruth.com/articles/new-hope-for-hair-loss/)
More... (http://www.thebaldtruth.com/articles/new-hope-for-hair-loss/)